Researchers optimistic in cancer fight, as disease spreads

Jun 08, 2010 by Jean-Louis Santini

Medical researchers are posting optimism in the long fight against cancer as advances were unveiled to combat the disease that continues to rise and remains the second biggest killer in the world.

"Our growing understanding of cancer's complex behavior is being translated into better, more targeted drugs against a variety of tumors," Douglas Blayney, president of the American Society of Clinical Oncology (ASCO), said at the group's annual meeting.

The most encouraging results unveiled in Chicago last week during the world's biggest gathering of experts demonstrated the growing role of therapies targeting key tumor functions or helping the immune system destroy instead of standard chemotherapy.

These advances showed increased rates of survival, particularly among patients with advanced or metastasized cancers, such as . There are few, if any, treatments against these types of cancers.

An experimental antibody known as ipilimumab activates the immune system's , which then seek and destroy melanoma cells, instead of targeting the cancer cell itself like previous treatments.

Researchers found the drug was the first to extend the lives of patients with advanced melanoma, the deadliest form of skin cancer. Melanoma cases have climbed faster than any other cancer type over the past 30 years.

Another new experimental drug, crizotinib was shown to shrink tumors in advanced lung cancer patients with a specific type of genetic alteration by neutralizing an enzyme implicated in cancer cell growth, known as anaplastic lymphoma kinase, or ALK.

Lung cancer is the most frequent and deadliest of all cancers worldwide.

Another clinical trial found that long-term treatment with the drug , which cuts off supply of nutrient-rich blood to tumors, may help control progress of advanced .

Adding to androgen deprivation therapy (ADT) was also found to cut by 43 percent the risk of death in men suffering from locally advanced or high-risk prostate cancer.

"We really want to improve the quality of life of the patients with fewer side effects and some of these new approaches really accomplished that," University of Pennsylvania professor of medicine Lynn Schuchter told AFP.

Driving home that point, the ASCO meeting devoted its theme this year to "advancing quality through innovation."

Despite the progress and improvement of care since president Richard Nixon declared war against cancer in 1971, the disease remains far too frequent in the United States.

The American Cancer Society (ACS) estimates that nearly 1.5 million new cases were recorded in 2009, killing over 560,000 people.

A recent report by the World Health Organization warned the number of cancer deaths could double worldwide by 2030, to reach 13 million.

As industrialized countries struggle to care for an aging population, nearly half of all men and one in three women will be diagnosed with cancer in their lives, according to the ACS.

Several types of cancers -- liver, pancreas, ovarian, lung and brain -- are particularly lethal and do not respond well to existing therapies.

But the incidence of cancer is tied to lifestyles, placing the onus on prevention efforts.

Nearly 40 percent of the drop in male cancer deaths from 1990 to 2006 owed to a reduction in , whose main culprit is smoking.

Explore further: World first as viral immunotherapy for skin cancer shows patient benefit in phase III trial

Related Stories

Drug boosts survival in major skin cancer study

Jun 05, 2010

(AP) -- Researchers have scored the first big win against melanoma, the deadliest form of skin cancer. An experimental drug significantly improved survival in a major study of people with very advanced disease.

New combination therapy safe, promising for melanoma patients

Jun 01, 2008

The combination of two different biotherapies may be beneficial for patients with inoperable melanoma, according to a University of Pittsburgh Cancer Institute (UPCI) study presented at the 44th annual meeting of the American ...

Recommended for you

Diagnosing cancer with help from bacteria

9 minutes ago

Engineers at MIT and the University of California at San Diego (UCSD) have devised a new way to detect cancer that has spread to the liver, by enlisting help from probiotics—beneficial bacteria similar to ...

ASCO: Many cancer patients interested in genetic profiling

59 minutes ago

(HealthDay)—Many patients with cancer are interested in comprehensive tumor genetic profiling (CGP), and most are willing to pay out-of-pocket costs for CGP, according to a study scheduled for presentation ...

Scientists identify key to preventing secondary cancers

1 hour ago

Leading scientists from the University of Sheffield and University of Copenhagen have identified a possible key to preventing secondary cancers in breast cancer patients, after discovering an enzyme which ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.